Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trialZobair M. Younossi, Victor Ankoma‐Sey, Quentin M. Anstee et al.|The Lancet|2019Cited by 1.2k
Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis GroupSimon Pape, Nanda Kerkar, Romée J.A.L.M. Snijders et al.|Journal of Hepatology|2022Cited by 172